Trials / Terminated
TerminatedNCT03296111
Patients With Ocular Neuropathic Pain: Description of Pain and Impact on Their Quality of Life
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 19 (actual)
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Some patients with dry eye may have severe disabling neuropathic pain. They describe spontaneous pain, dysesthesia, hyperalgesia or even allodynia. It is classical to note an important discordance between the high intensity of the symptoms and the poverty of the clinical signs. These pains are often unrecognized and therefore often not sufficiently treated. A significant impact on patient's quality of life may occur. The concept of ocular neuropathic pain being relatively recent, few studies have focused on the subject at present. Our study aims to shed light on these pains in patients consulting for dry eyes at the Ophthalmological Foundation A. de Rothschild. The objective of our study is to describe precisely the characteristics of neuropathic eye pain and the visual, general and psychological repercussions in these patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Questionnaires on pain and quality of life | Patients will be asked to complete several questionnaires about their pain and the impact on their quality of life. They will complete the questionnaires in the ophthalmology consultation room or at home and return it by mail (or present it at the next consultation). Patients will be asked to complete several questionnaires : * Questionnaire about the characteristics of ocular neuropathic pain (7 items) * DEQ-5 (Dry Eye Questionnaire) * ODI (Ocular Surface Disease Index) * BPI (Brief Pain Inventory) * HADS (Hospital Anxiety and Depression Scale) |
Timeline
- Start date
- 2017-05-04
- Primary completion
- 2017-06-19
- Completion
- 2019-10-28
- First posted
- 2017-09-28
- Last updated
- 2019-10-30
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03296111. Inclusion in this directory is not an endorsement.